Literature DB >> 11589927

Blood-pressure lowering for the secondary prevention of stroke.

J A Staessen1, J Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11589927     DOI： 10.1016/S0140-6736(01)06226-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.

Authors:  Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

2.  The PROGRESS trial three years later: time for a balanced report of effectiveness.

Authors:  Richard Wennberg; Camilla Zimmermann
Journal:  BMJ       Date:  2004-10-23

Review 3.  Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs.

Authors:  Rainer Düsing
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  [The heart in hypertension].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

Review 5.  Current and future concepts in stroke prevention.

Authors:  Fintan O'Rourke; Naeem Dean; Naveed Akhtar; Ashfaq Shuaib
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

6.  Fixed-dose combination therapy in hypertension: cons.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Giovanni Mazzotta; Marta Garofoli; Elisa Ramundo; Cristina Poltronieri; Paolo Verdecchia
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-06-01

7.  Short-term blood pressure variability - variation between arm side, body position and successive measurements: a population-based cohort study.

Authors:  Maria Elena Lacruz; Alexander Kluttig; Oliver Kuss; Daniel Tiller; Daniel Medenwald; Sebastian Nuding; Karin Halina Greiser; Stefan Frantz; Johannes Haerting
Journal:  BMC Cardiovasc Disord       Date:  2017-01-18       Impact factor: 2.298

Review 8.  Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.

Authors:  Ji-Guang Wang; Eduardo Pimenta; Frank Chwallek
Journal:  Vasc Health Risk Manag       Date:  2014-04-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.